Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Aubel

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Current Opinion in Genetics & Development|October 12, 2010
Watch the clock-engineering biological systems to be on timeDominique Aubel, Martin Fussenegger
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|March 19, 2010
Mammalian synthetic biology--from tools to therapiesDominique Aubel, Martin Fussenegger
Current Opinion in Chemical Biology|June 10, 2015
Novel theranostic agents for next-generation personalized medicine: small molecules, nanoparticles, and engineered mammalian cellsRyosuke Kojima, Dominique Aubel, Martin Fussenegger
Nature Biomedical Engineering|April 24, 2019
Synthetic gene circuits for the detection, elimination and prevention of diseaseFerdinand Sedlmayer, Dominique Aubel, Martin Fussenegger
Molecular Systems Biology|September 25, 2013
Biomedically relevant circuit-design strategies in mammalian synthetic biologyWilliam Bacchus, Dominique Aubel, Martin Fussenegger
Advanced Drug Delivery Reviews|May 19, 2016
Toward a world of theranostic medication: Programming biological sentinel systems for therapeutic interventionRyosuke Kojima, Dominique Aubel, Martin Fussenegger
Current Opinion in Chemical Biology|January 28, 2014
Synthetic mammalian gene circuits for biomedical applicationsHaifeng Ye, Dominique Aubel, Martin Fussenegger
Biotechnology Advances|September 4, 2013
An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseasesBoon Chin Heng, Dominique Aubel, Martin Fussenegger
Current Opinion in Biotechnology|February 14, 2015
Prosthetic gene networks as an alternative to standard pharmacotherapies for metabolic disordersBoon Chin Heng, Dominique Aubel, Martin Fussenegger
Nature Reviews. Genetics|March 12, 2026
Next-generation programmable cell therapies for precision medicineAna Palma Teixeira, Dominique Aubel, Martin Fussenegger
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Current Opinion in Genetics & Development|October 12, 2010
Watch the clock-engineering biological systems to be on timeDominique Aubel, Martin Fussenegger
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|March 19, 2010
Mammalian synthetic biology--from tools to therapiesDominique Aubel, Martin Fussenegger
Current Opinion in Chemical Biology|June 10, 2015
Novel theranostic agents for next-generation personalized medicine: small molecules, nanoparticles, and engineered mammalian cellsRyosuke Kojima, Dominique Aubel, Martin Fussenegger
Nature Biomedical Engineering|April 24, 2019
Synthetic gene circuits for the detection, elimination and prevention of diseaseFerdinand Sedlmayer, Dominique Aubel, Martin Fussenegger
Molecular Systems Biology|September 25, 2013
Biomedically relevant circuit-design strategies in mammalian synthetic biologyWilliam Bacchus, Dominique Aubel, Martin Fussenegger
Advanced Drug Delivery Reviews|May 19, 2016
Toward a world of theranostic medication: Programming biological sentinel systems for therapeutic interventionRyosuke Kojima, Dominique Aubel, Martin Fussenegger
Current Opinion in Chemical Biology|January 28, 2014
Synthetic mammalian gene circuits for biomedical applicationsHaifeng Ye, Dominique Aubel, Martin Fussenegger
Biotechnology Advances|September 4, 2013
An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseasesBoon Chin Heng, Dominique Aubel, Martin Fussenegger
Current Opinion in Biotechnology|February 14, 2015
Prosthetic gene networks as an alternative to standard pharmacotherapies for metabolic disordersBoon Chin Heng, Dominique Aubel, Martin Fussenegger
Nature Reviews. Genetics|March 12, 2026
Next-generation programmable cell therapies for precision medicineAna Palma Teixeira, Dominique Aubel, Martin Fussenegger
Pageof 4